Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.
Publication
, Journal Article
Zighelboim, I; Wright, JD; Powell, MA; Case, AS; Eisenhauer, EL; Cohn, DE; Valea, FA; Secord, AA; Lippmann, LT; Rader, JS
Published in: Journal of Clinical Oncology
May 20, 2010
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
TPS252 / TPS252
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Zighelboim, I., Wright, J. D., Powell, M. A., Case, A. S., Eisenhauer, E. L., Cohn, D. E., … Rader, J. S. (2010). Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer. Journal of Clinical Oncology, 28(15_suppl), TPS252–TPS252. https://doi.org/10.1200/jco.2010.28.15_suppl.tps252
Zighelboim, I., J. D. Wright, M. A. Powell, A. S. Case, E. L. Eisenhauer, D. E. Cohn, F. A. Valea, A. A. Secord, L. T. Lippmann, and J. S. Rader. “Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): TPS252–TPS252. https://doi.org/10.1200/jco.2010.28.15_suppl.tps252.
Zighelboim I, Wright JD, Powell MA, Case AS, Eisenhauer EL, Cohn DE, et al. Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer. Journal of Clinical Oncology. 2010 May 20;28(15_suppl):TPS252–TPS252.
Zighelboim, I., et al. “Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2010, pp. TPS252–TPS252. Crossref, doi:10.1200/jco.2010.28.15_suppl.tps252.
Zighelboim I, Wright JD, Powell MA, Case AS, Eisenhauer EL, Cohn DE, Valea FA, Secord AA, Lippmann LT, Rader JS. Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010 May 20;28(15_suppl):TPS252–TPS252.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
TPS252 / TPS252
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences